Access to innovative blood cancer treatment: Is it fast enough and equitable for all Canadians?
New cancer drugs are very expensive. Most Canadians could never afford them without public coverage, even if they sold their homes and borrowed money from everyone they knew. Canada does not provide universal pharmacare (drug coverage). Provincial coverage decisions are complex – affected by political interests, changes in government, advocacy efforts, population size, and regional […]
